S Sai Krishna

Employment

• Indian Immunologicals Ltd Deputy General Manager
  2014 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age
  Infectious Diseases 2024 DOI: 10.1080/23744235.2024.2410466
  +Save
• Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
  Vaccine 2023 DOI: 10.1016/j.vaccine.2023.08.084
  +Save
• Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study
  Vaccine 2023 DOI: 10.1016/j.vaccine.2023.08.065
  +Save
• Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study
  Vaccine 2021 DOI: 10.1016/j.vaccine.2021.03.012
  +Save
• Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6–8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study
  Vaccine 2019 DOI: 10.1016/j.vaccine.2019.06.067
  +Save